Article Information
History
- January 15, 2016.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mark A. DeWitt1,2,
- Wendy Magis3,
- Nicolas L. Bray1,2,
- Tianjiao Wang1,2,
- Jennifer R. Berman4,
- Fabrizia Urbinati5,
- Denise P. Muñoz3,
- Donald B. Kohn5,
- Mark C. Walters3,6,
- Dana Carroll1,7,*,
- David K. Martin3,* and
- Jacob E. Corn1,2,*
- 1Innovative Genomics Initiative, University of California-Berkeley, CA, USA
- 2Department of Molecular and Cellular Biology, University of California-Berkeley, CA, USA
- 3Children’s Hospital Oakland Research Institute, UCSF Benioff Children’s Hospital, Oakland, California, USA
- 4Digital Biology Center, Bio-Rad Laboratories, Pleasanton, CA, USA.
- 5Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA
- 6Blood & Marrow Program, Division of Hematology/Oncology/BMT, UCSF Benioff Children’s Hospital, Oakland, Oakland, CA, USA
- 7Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, USA
- ↵* Co-corresponding authors: Jacob Corn jcorn{at}berkeley.edu, David Martin dimartin{at}chori.org and Dana Carroll dana{at}biochem.utah.edu
Posted January 15, 2016.
Efficient Correction of the Sickle Mutation in Human Hematopoietic Stem Cells Using a Cas9 Ribonucleoprotein Complex
